Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells

Abstract Nicotinamide, the amide form of Vitamin B3, is a common nutrient supplement that plays important role in human fetal development. Nicotinamide has been widely used in clinical treatments, including the treatment of diseases during pregnancy. However, its impacts during embryogenesis have no...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ya Meng, Chengcheng Song, Zhili Ren, Xiaohong Li, Xiangyu Yang, Nana Ai, Yang Yang, Dongjin Wang, Meixiao Zhan, Jiaxian Wang, Chon Lok LEI, Weiwei Liu, Wei Ge, Ligong Lu, Guokai Chen
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/2b84dabf091b4432a2db621251135889
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2b84dabf091b4432a2db621251135889
record_format dspace
spelling oai:doaj.org-article:2b84dabf091b4432a2db6212511358892021-12-05T12:04:31ZNicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells10.1038/s41419-021-04395-z2041-4889https://doaj.org/article/2b84dabf091b4432a2db6212511358892021-11-01T00:00:00Zhttps://doi.org/10.1038/s41419-021-04395-zhttps://doaj.org/toc/2041-4889Abstract Nicotinamide, the amide form of Vitamin B3, is a common nutrient supplement that plays important role in human fetal development. Nicotinamide has been widely used in clinical treatments, including the treatment of diseases during pregnancy. However, its impacts during embryogenesis have not been fully understood. In this study, we show that nicotinamide plays multiplex roles in mesoderm differentiation of human embryonic stem cells (hESCs). Nicotinamide promotes cardiomyocyte fate from mesoderm progenitor cells, and suppresses the emergence of other cell types. Independent of its functions in PARP and Sirtuin pathways, nicotinamide modulates differentiation through kinase inhibition. A KINOMEscan assay identifies 14 novel nicotinamide targets among 468 kinase candidates. We demonstrate that nicotinamide promotes cardiomyocyte differentiation through p38 MAP kinase inhibition. Furthermore, we show that nicotinamide enhances cardiomyocyte survival as a Rho-associated protein kinase (ROCK) inhibitor. This study reveals nicotinamide as a pleiotropic molecule that promotes the derivation and survival of cardiomyocytes, and it could become a useful tool for cardiomyocyte production for regenerative medicine. It also provides a theoretical foundation for physicians when nicotinamide is considered for treatments for pregnant women.Ya MengChengcheng SongZhili RenXiaohong LiXiangyu YangNana AiYang YangDongjin WangMeixiao ZhanJiaxian WangChon Lok LEIWeiwei LiuWei GeLigong LuGuokai ChenNature Publishing GrouparticleCytologyQH573-671ENCell Death and Disease, Vol 12, Iss 12, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Cytology
QH573-671
spellingShingle Cytology
QH573-671
Ya Meng
Chengcheng Song
Zhili Ren
Xiaohong Li
Xiangyu Yang
Nana Ai
Yang Yang
Dongjin Wang
Meixiao Zhan
Jiaxian Wang
Chon Lok LEI
Weiwei Liu
Wei Ge
Ligong Lu
Guokai Chen
Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells
description Abstract Nicotinamide, the amide form of Vitamin B3, is a common nutrient supplement that plays important role in human fetal development. Nicotinamide has been widely used in clinical treatments, including the treatment of diseases during pregnancy. However, its impacts during embryogenesis have not been fully understood. In this study, we show that nicotinamide plays multiplex roles in mesoderm differentiation of human embryonic stem cells (hESCs). Nicotinamide promotes cardiomyocyte fate from mesoderm progenitor cells, and suppresses the emergence of other cell types. Independent of its functions in PARP and Sirtuin pathways, nicotinamide modulates differentiation through kinase inhibition. A KINOMEscan assay identifies 14 novel nicotinamide targets among 468 kinase candidates. We demonstrate that nicotinamide promotes cardiomyocyte differentiation through p38 MAP kinase inhibition. Furthermore, we show that nicotinamide enhances cardiomyocyte survival as a Rho-associated protein kinase (ROCK) inhibitor. This study reveals nicotinamide as a pleiotropic molecule that promotes the derivation and survival of cardiomyocytes, and it could become a useful tool for cardiomyocyte production for regenerative medicine. It also provides a theoretical foundation for physicians when nicotinamide is considered for treatments for pregnant women.
format article
author Ya Meng
Chengcheng Song
Zhili Ren
Xiaohong Li
Xiangyu Yang
Nana Ai
Yang Yang
Dongjin Wang
Meixiao Zhan
Jiaxian Wang
Chon Lok LEI
Weiwei Liu
Wei Ge
Ligong Lu
Guokai Chen
author_facet Ya Meng
Chengcheng Song
Zhili Ren
Xiaohong Li
Xiangyu Yang
Nana Ai
Yang Yang
Dongjin Wang
Meixiao Zhan
Jiaxian Wang
Chon Lok LEI
Weiwei Liu
Wei Ge
Ligong Lu
Guokai Chen
author_sort Ya Meng
title Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells
title_short Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells
title_full Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells
title_fullStr Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells
title_full_unstemmed Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells
title_sort nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells
publisher Nature Publishing Group
publishDate 2021
url https://doaj.org/article/2b84dabf091b4432a2db621251135889
work_keys_str_mv AT yameng nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT chengchengsong nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT zhiliren nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT xiaohongli nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT xiangyuyang nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT nanaai nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT yangyang nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT dongjinwang nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT meixiaozhan nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT jiaxianwang nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT chonloklei nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT weiweiliu nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT weige nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT ligonglu nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
AT guokaichen nicotinamidepromotescardiomyocytederivationandsurvivalthroughkinaseinhibitioninhumanpluripotentstemcells
_version_ 1718372244304953344